AU2001290685A1 - Methods for inhibiting inflammatory disease - Google Patents
Methods for inhibiting inflammatory diseaseInfo
- Publication number
- AU2001290685A1 AU2001290685A1 AU2001290685A AU9068501A AU2001290685A1 AU 2001290685 A1 AU2001290685 A1 AU 2001290685A1 AU 2001290685 A AU2001290685 A AU 2001290685A AU 9068501 A AU9068501 A AU 9068501A AU 2001290685 A1 AU2001290685 A1 AU 2001290685A1
- Authority
- AU
- Australia
- Prior art keywords
- methods
- inflammatory disease
- inhibiting inflammatory
- inhibiting
- disease
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/235—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Emergency Medicine (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US09656144 | 2000-09-06 | ||
US09/656,144 US6433012B1 (en) | 1998-03-25 | 2000-09-06 | Method for inhibiting inflammatory disease |
PCT/US2001/028155 WO2002020004A1 (en) | 2000-09-06 | 2001-09-06 | Methods for inhibiting inflammatory disease |
Publications (1)
Publication Number | Publication Date |
---|---|
AU2001290685A1 true AU2001290685A1 (en) | 2002-03-22 |
Family
ID=24631819
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2001290685A Abandoned AU2001290685A1 (en) | 2000-09-06 | 2001-09-06 | Methods for inhibiting inflammatory disease |
Country Status (3)
Country | Link |
---|---|
US (1) | US6433012B1 (en) |
AU (1) | AU2001290685A1 (en) |
WO (1) | WO2002020004A1 (en) |
Families Citing this family (25)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6875165B2 (en) | 2001-02-22 | 2005-04-05 | Retinalabs, Inc. | Method of radiation delivery to the eye |
PT1569695E (en) | 2002-11-13 | 2013-07-16 | Genzyme Corp | Antisense modulation of apolipoprotein b expression |
WO2004044181A2 (en) | 2002-11-13 | 2004-05-27 | Isis Pharmaceuticals, Inc. | Antisense modulation of apolipoprotein b expression |
WO2005079294A2 (en) | 2004-02-12 | 2005-09-01 | Neo Vista, Inc. | Methods and apparatus for intraocular brachytherapy |
US7598080B2 (en) * | 2004-08-20 | 2009-10-06 | Carl Deirmengian | Diagnostic assay for source of inflammation |
US20080119367A1 (en) * | 2004-12-17 | 2008-05-22 | Mayo Foundation For Medical Education And Research | Prognosis of Renal Cell Carcinoma |
JP2009515655A (en) | 2005-11-15 | 2009-04-16 | ネオビスタ、インコーポレイテッド | Method and apparatus for intraocular brachytherapy |
GB0622688D0 (en) * | 2006-11-14 | 2006-12-27 | Diosamine Dev Corp | Novel compounds |
US7850382B2 (en) | 2007-01-18 | 2010-12-14 | Sanford, L.P. | Valve made from two materials and writing utensil with retractable tip incorporating same |
US7488130B2 (en) | 2007-02-01 | 2009-02-10 | Sanford, L.P. | Seal assembly for retractable instrument |
US20090192098A1 (en) | 2007-11-21 | 2009-07-30 | Oxigene, Inc. | Method for treating hematopoietic neoplasms |
US8226312B2 (en) | 2008-03-28 | 2012-07-24 | Sanford, L.P. | Valve door having a force directing component and retractable instruments comprising same |
CA2724327A1 (en) | 2008-06-04 | 2009-12-10 | Neovista, Inc. | Handheld radiation delivery system for advancing a radiation source wire |
US8221012B2 (en) | 2008-11-07 | 2012-07-17 | Sanford, L.P. | Retractable instruments comprising a one-piece valve door actuating assembly |
US8393814B2 (en) | 2009-01-30 | 2013-03-12 | Sanford, L.P. | Retractable instrument having a two stage protraction/retraction sequence |
EP3418397B1 (en) | 2012-01-24 | 2020-10-07 | CD Diagnostics, Inc. | System for detecting infection in synovial fluid |
US9353150B2 (en) | 2012-12-04 | 2016-05-31 | Massachusetts Institute Of Technology | Substituted pyrazino[1′,2′:1 ,5]pyrrolo[2,3-b]-indole-1,4-diones for cancer treatment |
WO2014144715A1 (en) | 2013-03-15 | 2014-09-18 | Memorial Sloan-Kettering Cancer Center | Hsp90-targeted cardiac imaging and therapy |
WO2016033424A1 (en) | 2014-08-29 | 2016-03-03 | Genzyme Corporation | Methods for the prevention and treatment of major adverse cardiovascular events using compounds that modulate apolipoprotein b |
EP3337495A4 (en) | 2015-08-18 | 2019-04-10 | Mateon Therapeutics, Inc. | Use of vdas to enhance immunomodulating therapies against tumors |
WO2017197045A1 (en) | 2016-05-11 | 2017-11-16 | Movassaghi Mohammad | Convergent and enantioselective total synthesis of communesin analogs |
WO2018209239A1 (en) | 2017-05-11 | 2018-11-15 | Massachusetts Institute Of Technology | Potent agelastatin derivatives as modulators for cancer invasion and metastasis |
US10640508B2 (en) | 2017-10-13 | 2020-05-05 | Massachusetts Institute Of Technology | Diazene directed modular synthesis of compounds with quaternary carbon centers |
US11535634B2 (en) | 2019-06-05 | 2022-12-27 | Massachusetts Institute Of Technology | Compounds, conjugates, and compositions of epipolythiodiketopiperazines and polythiodiketopiperazines and uses thereof |
US12030888B2 (en) | 2021-02-24 | 2024-07-09 | Massachusetts Institute Of Technology | Himastatin derivatives, and processes of preparation thereof, and uses thereof |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5001116A (en) * | 1982-12-20 | 1991-03-19 | The Children's Medical Center Corporation | Inhibition of angiogenesis |
US4994443A (en) * | 1982-12-20 | 1991-02-19 | The Children's Medical Center Corporation | Inhibition of angiogenesis |
US5013556A (en) * | 1989-10-20 | 1991-05-07 | Liposome Technology, Inc. | Liposomes with enhanced circulation time |
JP3880064B2 (en) * | 1994-04-26 | 2007-02-14 | ザ チルドレンズ メディカル センター コーポレイション | Angiostatin and its use in inhibiting angiogenesis |
US5583153A (en) * | 1994-10-06 | 1996-12-10 | Regents Of The University Of California | Use of taxol in the treatment of rheumatoid arthritis |
US6017958A (en) * | 1996-06-04 | 2000-01-25 | Octamer, Inc. | Method of treating malignant tumors with thyroxine analogues having no significant hormonal activity |
US5736576A (en) * | 1996-06-04 | 1998-04-07 | Octamer, Inc. | Method of treating malignant tumors with thyroxine analogues having no significant hormonal activity |
EP1003498A4 (en) * | 1997-03-26 | 2004-07-14 | Biosource Tech Inc | Di-aryl ethers and their derivatives as anti-cancer agents |
US5922775A (en) * | 1997-10-23 | 1999-07-13 | Octamer, Inc. | Method of treating malignant tumors with ketone thyroxine analogues having no significant hormonal activity |
-
2000
- 2000-09-06 US US09/656,144 patent/US6433012B1/en not_active Expired - Fee Related
-
2001
- 2001-09-06 WO PCT/US2001/028155 patent/WO2002020004A1/en active Application Filing
- 2001-09-06 AU AU2001290685A patent/AU2001290685A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
US6433012B1 (en) | 2002-08-13 |
WO2002020004A1 (en) | 2002-03-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2001290685A1 (en) | Methods for inhibiting inflammatory disease | |
AU2001288271A1 (en) | Methods for treating inflammatory diseases | |
AU2001258771A1 (en) | -secretase inhibitors | |
HUP0303622A3 (en) | Emedies for inflammatory bowel diseases | |
AU2002225730A1 (en) | Compounds | |
AU2001254546A1 (en) | Aminopiperidines | |
AU2000267458A1 (en) | Hypercomputer | |
AU2001239310A1 (en) | Decahydro-isoquinolines | |
AU2001220246A1 (en) | Neckphone | |
AU2001258349A1 (en) | Bisacylguanidine | |
EP1215910A3 (en) | Watermarking | |
AUPQ661800A0 (en) | Insulin-potentiating compounds | |
AU2001227953A1 (en) | Methods for raising rabbits | |
AU2001263909A1 (en) | Diphenylmethane derivatives | |
AU5256301A (en) | Froindazole derivative | |
AU2001265871A1 (en) | Substituted sulfonylaminopyrimidines | |
AU2001258255A1 (en) | Substituted benzoylcyclohexenones | |
AU2001254731A1 (en) | Substituted phenyluracils | |
AU2608301A (en) | Methods for inhibiting mastocytosis | |
AU2001220281A1 (en) | Rollerboard for road-skiing | |
AU2002225724A1 (en) | Motilide compounds | |
AU2001266176A1 (en) | Methods | |
AU2001246864A1 (en) | Hypotensors | |
AU2001250536A1 (en) | Methods | |
AU2002220757A1 (en) | Method for obtaining azaerythromycin |